Skip to main navigation Skip to search Skip to main content

A Double-Blind, Randomized, Controlled Phase III Study to assess the Prophylactic Efficacy and Safety of gD-Alum/MPL Vaccine in the Prevention of Genital Herpes Disease in Young Women who are HSV-1 and -2 Seronegative

Stony Brook University

Project: Research

Project Details

StatusFinished
Effective start/end date10/22/04 → 08/31/11

Funding

  • National Institute of Allergy & Infectious Disease: $80,555.73